ESR1 and breast cancer: Our study analyzed the prognostic role of highly expressed RRM2 in various breast cancer subtypes, and finally we focused on the prognostic role of RRM2 in Luminal A breast cancer—an estrogen receptor-positive subtype of breast cancer.